Stratasys (SSYS) 6-K Condensed Consolidated Interim Financial Statements

Exhibit 99.1

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED

MARCH 31, 2023

(UNAUDITED)

1

INDEX TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2023

(UNAUDITED)

Item	Page
Consolidated Balance Sheets	2
Consolidated Statements of Operations and Comprehensive Loss	3
Consolidated Statements of Changes in Equity	4-5
Consolidated Statements of Cash Flows	6
Notes to Condensed Consolidated Interim Financial Statements	7-18

1

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Balance Sheets
(in thousands, except per share data)
		March 31, 2023			December 31, 2022
ASSETS
Current assets
Cash and cash equivalents	$	209,139		$	150,470
Short-term deposits		78,448			177,367
Accounts receivable, net of allowance for credit losses of $0.8 million and $0.9 million as of March 31, 2023 and December 31, 2022, respectively		144,519			144,739
Inventories		201,997			194,054
Prepaid expenses		8,466			5,767
Other current assets		22,468			27,823
Total current assets		665,037			700,220
Non-current assets
Property, plant and equipment, net		196,986			195,063
Goodwill		69,735			64,953
Other intangible assets, net		129,756			121,402
Operating lease right-of-use assets		16,884			18,122
Long-term investments		140,621			141,610
Other non-current assets		18,076			18,420
Total non-current assets		572,058			559,570
Total assets	$	1,237,095		$	1,259,790
LIABILITIES AND EQUITY
Current liabilities
Accounts payable	$	54,834		$	72,921
Accrued expenses and other current liabilities		49,554			45,912
Accrued compensation and related benefits		37,261			34,432
Deferred revenues - short term		53,774			50,220
Operating lease liabilities - short term		6,724			7,169
Total current liabilities		202,147			210,654
Non-current liabilities
Deferred revenues - long term		25,439			25,214
Deferred income taxes - long term		7,075			5,638
Operating lease liabilities - long term		9,880			10,670
Contingent consideration - long term		24,222			23,707
Other non-current liabilities		23,869			24,475
Total non-current liabilities		90,485			89,704
Total liabilities	$	292,632		$	300,358
Contingencies (see note 12)
Equity
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousand shares; 68,103 thousand shares and 67,086 thousand shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	$	190		$	187
Additional paid-in capital		3,057,157			3,048,915
Accumulated other comprehensive loss		(13,808	)		(12,818	)
Accumulated deficit		(2,099,076	)		(2,076,852	)
Total equity		944,463			959,432
Total liabilities and equity	$	1,237,095		$	1,259,790

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

2

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Operations and Comprehensive Loss
(in thousands, except per share data)
	Three Months Ended March 31,
		2023			2022
Revenues
Products	$	100,971		$	113,073
Services		48,406			50,356
		149,377			163,429
Cost of revenues
Products		51,113			59,373
Services		32,869			34,379
		83,982			93,752
Gross profit		65,395			69,677
Operating expenses
Research and development, net		21,475			23,998
Selling, general and administrative		60,717			65,263
		82,192			89,261
Operating loss		(16,797	)		(19,584	)
Financial income (expenses), net		773			(1,362	)
Loss before income taxes		(16,024	)		(20,946	)
Income tax benefit (expenses)		(3,775	)		73
Share in losses of associated companies		(2,425	)		(75	)
Net loss	$	(22,224	)	$	(20,948	)
Net loss per share - basic and diluted	$	(0.33	)	$	(0.32	)
Weighted average ordinary shares outstanding - basic and diluted		67,583			65,721
Comprehensive loss
Net loss		(22,224	)		(20,948	)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments		(2,245	)		(702	)
Unrealized gains (losses) on derivatives designated as cash flow hedges		1,255			(351	)
Other comprehensive income (loss), net of tax		(990	)		(1,053	)
Comprehensive loss	$	(23,214	)	$	(22,001	)

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

3

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Changes in Equity
(in thousands )
Three Months Ended March 31, 2023
											Accumulated
						Additional					Other
	Ordinary Shares					Paid-In		Accumulated			Comprehensive			Total
		Number of shares		Par Value		Capital		deficit			Loss			Equity
Balance as of December 31, 2022		67,086	$	187	$	3,048,915	$	(2,076,852	)	$	(12,818	)	$	959,432
Issuance of shares in connection with stock-based compensation plans		1,017		3		1		-			-			4
Stock-based compensation		-		-		8,241		-			-			8,241
Comprehensive loss		-		-		-		(22,224	)		(990	)		(23,214	)
Balance as of March 31, 2023		68,103	$	190	$	3,057,157	$	(2,099,076	)	$	(13,808	)	$	944,463

 The accompanying notes are an integral part of these condensed consolidated interim financial statements.

4

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Changes in Equity
(in thousands )
Three Months Ended March 31, 2022
											Accumulated
						Additional					Other
	Ordinary Shares					Paid-In		Accumulated			Comprehensive			Total
		Number of shares		Par Value		Capital		deficit			Loss			Equity
Balance as of December 31, 2021		65,677	$	182	$	3,012,481	$	(2,047,878	)	$	(8,771	)	$	956,014
Issuance of shares in connection with stock-based compensation plans		731		3		152		-			-			155
Stock-based compensation		-		-		8,533		-			-			8,533
Comprehensive income (loss)		-		-		-		(20,948	)		(1,053	)		(22,001	)
Balance as of March 31, 2022		66,408	$	185	$	3,021,166	$	(2,068,826	)	$	(9,824	)	$	942,701

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

5

STRATASYS LTD.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

Consolidated Statements of Cash Flows
(in thousands)	Three Months Ended March 31,
		2023			2022
Cash flows from operating activities
Net loss	$	(22,224	)	$	(20,948	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		11,680			15,290
Stock-based compensation		8,241			8,533
Foreign currency transaction loss		531			2,792
Share in losses of associated companies		2,425			75
Revaluation of investments		1,042			1,061
Other non-cash items, net		(95	)		83
Change in cash attributable to changes in operating assets and liabilities:
Accounts receivable, net		1,081			(7,950	)
Inventories		(10,123	)		(14,775	)
Other current assets and prepaid expenses		2,945			7,386
Other non-current assets		2,746			(85	)
Accounts payable		(18,547	)		7,194
Other current liabilities		1,622			(16,037	)
Deferred revenues		3,387			2,522
Deferred income taxes, net and uncertain tax positions		2,581			(381	)
Other non-current liabilities		(5,218	)		(823	)
Net cash used in operating activities		(17,926	)		(16,063	)
Cash flows from investing activities
Cash paid for acquisitions, net of cash acquired		(16,480	)		-
Purchase of property and equipment		(3,723	)		(3,741	)
Investments in short-term bank deposits		(12,448	)		(40,000	)
Proceeds from short-term bank deposits		111,367			117,000
Purchase of intangible assets		(311	)		(444	)
Other investing activities		(30	)		(47	)
Investments in unconsolidated entities		(2,453	)		(5,030	)
Net cash provided by investing activities		75,922			67,738
Cash flows from financing activities
Proceeds from exercise of stock options		4			155
Other financing activities		851			866
Net cash provided by financing activities		855			1,021
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(168	)		(2,228	)
Net change in cash, cash equivalents and restricted cash		58,683			50,468
Cash, cash equivalents and restricted cash, beginning of period		150,686			243,293
Cash, cash equivalents and restricted cash, end of period	$	209,369		$	293,761
Supplemental disclosures of cash flow information:
Transfer of inventory to fixed assets		3,604			188
Transfer of fixed assets to inventory		97			120
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:
Cash and cash equivalents		209,139			293,649
Restricted cash included in other current assets		230			112
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows	$	209,369		$	293,761

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

6

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 1. Business Description and Basis of Presentation

Stratasys Ltd. (collectively with its subsidiaries, the “Company” or “Stratasys”) is a global leader in connected, polymer-based 3D printing solutions, across the entire manufacturing value chain. The Company leverages its competitive advantages, which include a broad set of best-in-class 3D printing platforms, software, a materials and technology partner ecosystem, innovative leadership, and global GTM infrastructure, in order to position itself to capture share in a significant and growing global marketplace, with a focus on manufacturing, which the Company views as having the largest and fastest growing total addressable market. The Company’s approximately 1,700 granted and pending additive technology patents to date have been used to create models, prototypes, manufacturing tools, and production parts for a multitude of industries including aerospace, automotive, transportation, healthcare, consumer products, dental, medical, fashion and education. Stratasys’ products and comprehensive solutions improve product quality, development time, cost, time-to-market and patient care. The Company’s 3D ecosystem of solutions and expertise includes 3D printers, materials, software, expert services, and on-demand parts production.

The condensed consolidated interim financial information herein is unaudited; however, such information reflects all adjustments (consisting of normal, recurring adjustments), which are, in the opinion of management, necessary for a fair statement of results for the interim period. The condensed consolidated interim financial statements include the accounts of Stratasys Ltd. and its subsidiaries. All intercompany accounts and transactions, including profits from intercompany sales not yet realized outside the Company, have been eliminated in consolidation.

The Company’s financial statements are prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), which require the Company to make estimates based on assumptions about current and, for some estimates, future economic and market conditions which affect reported amounts and related disclosures in its financial statements. Although the Company’s current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from the Company’s expectations, which could materially affect its results of operations and financial position.

In particular, a number of estimates have been and will continue to be affected by the trends that have arisen in the aftermath of the COVID-19 pandemic, including global events and other longer-term macroeconomic conditions, most prominently, rising inflation, increasing interest rates, tightening of capital markets and global supply chain delays. As a result, the accounting estimates and assumptions may change over time. Such changes could have an additional impact on the Company’s long-lived asset and intangible asset valuation; and the allowance for expected credit losses. These consolidated financial statements reflect the financial statement effects based upon management’s estimates and assumptions utilizing the most currently available information.

The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results that could be expected for the entire fiscal year. Certain financial information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. The reader is referred to the Company's audited consolidated financial statements and notes thereto for the year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 3, 2023 as part of the Company’s Annual Report on Form 20-F for such year.

Note 2. New Accounting Pronouncements

Accounting Pronouncements Adopted in 2023

      In October 2021, the FASB issued ASU 2021-08 “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. The guidance will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. The guidance should be applied prospectively to acquisitions occurring on or after the effective date. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2023, with no material impact on its consolidated financial statements.

7

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 3. Certain Transactions

    MakerBot and Ultimaker transaction ("Ultimaker")

     On August 31, 2022, Stratasys completed the merger of MakerBot (previously, a fully owned subsidiary) with Ultimaker, which together formed a new entity under the name Ultimaker. The Company recorded a net gain of $39.1 million from deconsolidation of MakerBot, representing the difference between the book value of MakerBot's net assets and the fair value allocated to such net assets in the transaction as follows:

		U.S. $ in thousands
Fair value, net	$	55,751
Net assets deconsolidated		(14,146	)
Transaction expenses		(2,469	)
Gain on deconsolidation of subsidiary	$	39,136

     The Company accounts for its investment in the combined company Ultimaker according to the equity method in accordance with ASC Topic 323, as it has retained the ability to exercise significant influence but does not control the new entity. The Company recognized an equity method investment in a total amount of $105.6 million comprised of the assumed fair value of the MakerBot shares and additional amount invested in cash by the Company, representing a share of 46.5% in the new entity.

  The preliminary allocation of the purchase price ("PPA") to net assets acquired and liability assumed resulted in the recognition of intangible assets with a value of $57.8 million, goodwill of $22.3 million and other net assets of $25.5 million. The value assigned to intangible assets is amortized over a period of 5 to 10 years and the related amortization is included under share in net losses (profits) from associated companies. The estimated fair values are preliminary and based on the information that was available as of August 31, 2022. Thus, the measurements of fair value reflected in these assets are subject to changes and such changes could be significant.

    As of March 31, 2023 and December 31, 2022 the equity investment in Ultimaker amounted to $97.8 million and $100.2 million, respectively, which represented the original investment in Ultimaker, net of share in net losses for the period in amounts of $2.3 million and $5.4 million, respectively. Following the acquisition, the Company will act as an agent to Ultimaker and will distribute products of Ultimaker. Transactions with Ultimaker for the period were immaterial.

 Covestro acquisition

     On August 8, 2022, the Company announced that it signed a definitive agreement to acquire the additive manufacturing materials business of Covestro AG. On April 3, 2023 the Company completed the acquisition of Covestro. The purchase price was approximately $46.7 million (Euro 43 million) in cash (which is subject to adjustment to reflect the amount of inventory acquired under the Covestro asset purchase agreement, and the accrual with respect to liabilities being assumed under the Covestro asset purchase agreement), as well as 317,505 newly issued Stratasys ordinary shares, par value 0.01 New Israeli Shekels per share (“Stratasys ordinary shares”) as the consideration for the purchased assets. Under the terms of the Covestro asset purchase agreement, Covestro may also earn up to an additional Euro 37 million of consideration, subject to the achievement of specified performance metrics, which will be payable via the issuance of additional Stratasys ordinary shares.

    Other investments

    In addition to the investment in Ultimaker, other investments included under Long-term investments primarily consist of investments in non-marketable equity securities of several companies without readily determinable fair value in which the Company does not have a controlling interest or significant influence. During the first quarter of 2023 and during 2022, the Company invested a total of $2.4 million and $16.7 million, respectively, in non-marketable equity securities and convertible notes of several companies.

8

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 4. Revenues

Disaggregation of Revenues

The following table presents the Company’s revenues disaggregated by geographical region (based on the Company’s customers’ locations) and revenue type for the three months ended March 31, 2023 and 2022:

	Three months ended March 31,
		2023		2022
	(U.S. $ in thousands)
Americas
Systems	$	21,186	$	28,982
Consumables		32,572		31,354
Service		36,322		38,231
Total Americas		90,080		98,567
EMEA
Systems		11,402		15,076
Consumables		18,911		17,825
Service		7,567		7,153
Total EMEA		37,880		40,055
Asia Pacific
Systems		7,864		10,458
Consumables		9,036		9,377
Service		4,517		4,972
Total Asia Pacific		21,417		24,807
Total Revenues	$	149,377	$	163,429

The following table presents the Company’s revenues disaggregated based on the timing of revenue recognition (at a specific point in time or over the course of time) for the three months ended March 31, 2023 and 2022:

	Three months ended March 31,
		2023		2022
	(U.S. $ in thousands)
Revenues recognized in point in time from:
Products	$	100,971	$	113,073
Services		13,691		12,492
Total revenues recognized in point in time		114,662		125,565
Revenues recognized over time from:
Services		34,715		37,864
Total revenues recognized over time		34,715		37,864
Total Revenues	$	149,377	$	163,429

9

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Contract Assets and Contract Liabilities

Contract assets are recorded when the Company’s right to consideration is conditional on constraints other than the passage of time. The Company had no material contract assets as of March 31, 2023 and December 31, 2022.

Contract liabilities include advance payments and billings in excess of revenue recognized, which are primarily related to advanced billings for service type warranty. Contract liabilities are presented under deferred revenue. The Company’s deferred revenue as of March 31, 2023 and December 31, 2022 was as follows:

		March 31,		December 31,
		2023		2022
	U.S. $ in thousands
Deferred revenue*	$	79,213	$	75,434

*Includes $25.4 million and $25.2 million under long term deferred revenue in the Company's consolidated balance sheets as of March 31, 2023 and December 31, 2022, respectively.

Revenue recognized in 2023 that was included in deferred revenue balance as of December 31, 2022 was $16.1 million for the three months ended March 31, 2023.

Remaining Performance Obligations

Remaining Performance Obligations (“RPO“) represent contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of March 31, 2023, the total RPO amounted to $111.9 million. The Company expects to recognize $79.1 million of this RPO during the next 12 months, $19.1 million over the subsequent 12 months and the remaining $13.7 million thereafter.

Incremental Costs of Obtaining a Contract

Sales commissions earned mainly by the Company’s sales agents are considered incremental costs of obtaining a contract with a customer, as the Company expects the benefit of those commissions to be longer than one year. The majority of the sales commissions are not subject to capitalization, as the commission expense is recognized as the related revenue is recognized. Sales commissions for initial contracts related to the service type warranty are deferred and then amortized on a straight-line basis over the expected customer relationship period if the Company expects to recover those costs. Amortization expense is included in selling, general and administrative expenses in the consolidated statements of operations. As of March 31, 2023 and December 31, 2022, the deferred commissions amounted to $9.5 million and $9.6 million, respectively.

10

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 5. Inventories

Inventories consisted of the following:

		March 31,		December 31,
		2023		2022
	U.S. $ in thousands
Finished goods	$	86,214	$	81,564
Work-in-process		8,319		7,562
Raw materials		107,464		104,928
	$	201,997	$	194,054

Note 6. Goodwill and Other Intangible Assets

      Goodwill

Changes in the carrying amount of the Company’s goodwill during the three months ended March 31, 2023 were as follows:

		U.S. $ in thousands
Goodwill as of January 1, 2023	$	64,953
Goodwill acquired		4,743
Foreign currency translation adjustments		39
Goodwill as of March 31, 2023	$	69,735

       

11

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

   

      Other Intangible Assets

Other intangible assets consisted of the following:

	March 31, 2023							December 31, 2022
		Carrying Amount,					Net		Carrying Amount,					Net
		Net of		Accumulated			Book		Net of		Accumulated			Book
		Impairment		Amortization			Value		Impairment		Amortization			Value
	U.S. $ in thousands
Developed technology	$	392,867	$	(287,704	)	$	105,163	$	387,603	$	(283,671	)	$	103,932
Patents		17,808		(9,302	)		8,506		17,508		(8,970	)		8,538
Trademarks and trade names		17,291		(14,328	)		2,963		16,278		(14,030	)		2,248
Customer relationships		101,619		(88,495	)		13,124		93,609		(86,925	)		6,684
Capitalized software development costs		7,066		(7,066	)		-		7,066		(7,066	)		-
	$	536,651	$	(406,895	)	$	129,756	$	522,064	$	(400,662	)	$	121,402

Amortization expenses relating to intangible assets for the three-month period ended March 31, 2023 and 2022 were approximately $6.2 million and $9.2 million, respectively.

As of March 31, 2023, the estimated amortization expenses relating to intangible assets for each of the following future periods were as follows:

		Estimated
		amortization expenses
		(U.S. $ in thousands)
Remaining 9 months of 2023	$	19,362
2024		21,627
2025		19,149
2026		19,063
2027		18,099
2028 and thereafter		32,456
Total	$	129,756

12

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 7. Net Loss Per Share

The following table presents the numerator and denominator of the basic and diluted net loss per share computations for the three months ended March 31, 2023 and 2022:

	Three Months Ended March 31,
		2023			2022
	(In thousands, except per share amounts)
Numerator:
Net loss for basic and diluted loss per share	$	(22,224	)	$	(20,948	)
Denominator:
Weighted average shares - for basic and diluted net loss per share		67,583			65,721
Net loss per share
Basic and diluted	$	(0.33	)	$	(0.32	)

The computation of diluted net loss per share excluded share awards of 3.4 million and 5.4 million shares for the three months ended March 31, 2023 and 2022, respectively, because the inclusion of those shares would have had an anti-dilutive effect on the diluted net loss per share.

Note 8. Income Taxes

        The Company had tax expense of $3.8 million for the three-month period ended March 31, 2023 compared to tax benefit of $0.1 million for the three-month period ended March 31, 2022. The Company’s effective tax rate as of March 31, 2023 was primarily impacted by the geographic mix of its earnings and losses, movements in its valuation allowance and changes in its uncertain tax positions. 

13

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 9. Fair Value Measurements

The following table summarizes the Company’s financial assets and liabilities that are carried at fair value on a recurring basis, in its consolidated balance sheets:

	March 31, 2023				December 31, 2022
		Level 2		Level 3		Level 2		Level 3
	(U.S. $ in thousands)
Assets:
Foreign exchange forward contracts not designated as hedging instruments	$	73		-	$	159		-
Foreign exchange forward contracts designated as hedging instruments		220		-		3		-
Liabilities:
Foreign exchange forward contracts not designated as hedging instruments		(100	)	-		(38	)	-
Foreign exchange forward contracts designated as hedging instruments		(2,610	)	-		(1,640	)	-
Convertible notes				4,327		-		1,894
Contingent consideration*				38,606		-		38,341
		(2,417	)	42,933		(1,516	)	40,235

*Includes $14.4 million and $14.6 million under Accrued expenses and other current liabilities in the Company's consolidated balance sheets as of March 31, 2023 and December 31, 2022, respectively.

The Company’s foreign exchange forward contracts are classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs, including interest rate curves and both forward and spot prices for currencies (Level 2 inputs).

Contingent consideration represents liabilities recorded at fair value in connection with acquisitions, and thus represents a Level 3 measurement within the fair value hierarchy (refer to Note 3).

Other financial instruments consist mainly of cash and cash equivalents, short-term deposits, current and non-current receivables, accounts payable and other current liabilities. The fair value of these financial instruments approximates their carrying values.

14

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 10. Derivative instruments and hedging activities

Since the Company conducts its operations globally, it is exposed to global market risks and to the risk that its earnings, cash flows and equity could be adversely impacted by fluctuations in foreign currency exchange rates. The Company enters into transactions involving foreign currency exchange derivative financial instruments. The Company manages its foreign currency exposures on a consolidated basis, which allows the Company to net exposures and take advantage of any natural hedging. The transactions are designed to manage the Company’s net exposure to foreign currency exchange rates and to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates. The Company does not enter into derivative transactions for trading purposes.

The Company is primarily exposed to foreign exchange risk with respect to recognized assets and liabilities and forecasted transactions denominated in New Israeli Shekels (“NIS”), Euro, British Pound, Korean Won, Chinese Yuan and the Japanese Yen. The gains and losses on the hedging instruments partially offset losses and gains on the hedged items. Financial markets and currency volatility may limit the Company’s ability to hedge these exposures. These contracts mature through December 2023.

The following table summarizes the consolidated balance sheets classification and fair values of the Company’s derivative instruments:

		Fair Value						Notional Amount
			March 31,			December 31,			March 31,		December 31,
	Balance sheet location		2023			2022			2023		2022
		U.S. $ in thousands
Assets derivatives -Foreign exchange contracts, not designated as hedging instruments	Other current assets	$	73		$	159		$	40,375	$	101,733
Assets derivatives -Foreign exchange contracts, designated as cash flow hedge	Other current assets		220			3			31,480		4,900
Liability derivatives -Foreign exchange contracts, not designated as hedging instruments	Accrued expenses and other current liabilities		(100	)		(38	)		22,311		16,751
Liability derivatives -Foreign exchange contracts, designated as hedging instruments	Accrued expenses and other current liabilities		(2,610	)		(1,640	)		52,115		72,273
		$	(2,417	)	$	(1,516	)	$	146,281	$	195,657

Foreign exchange contracts not designated as hedging instruments

As of March 31, 2023, the notional amounts of the Company’s outstanding exchange forward contracts, not designated as hedging instruments, were $62.7 million, and were used to reduce foreign currency exposures of the Euro, NIS, Japanese Yen, Korean Won and Chinese Yuan. With respect to such derivatives, loss of $0.4 million and gain of $0.7 million were recognized under financial income, net for the three-month period ended March 31, 2023 and 2022, respectively. Such gains or losses partially offset the foreign currency revaluation changes of the balance sheet items. These foreign currencies revaluation changes are also recognized under financial income, net.

Cash Flow Hedging - Hedges of forecasted foreign currency payroll and other operating expenses

As of March 31, 2023, the Company had in effect foreign exchange forward contracts, designated as cash flow hedges for accounting purposes, for the conversion of $48.9 million into NIS. The Company uses short-term cash flow hedge contracts to reduce its exposure to variability in expected future cash flows resulting mainly from payroll costs and other operating expenses denominated in NIS. The changes in fair value of those contracts are included in the Company’s accumulated other comprehensive loss.

Cash Flow Hedging - Hedges of forecasted foreign currency revenue

As of March 31, 2023, the Company had in effect foreign exchange forward contracts, designated as cash flow hedges for accounting purposes, for the conversion of 34.7 million Euro into U.S. dollars. The Company transacts business in U.S. dollars and in various other currencies. The Company may use foreign exchange or forward contracts to hedge certain cash flow exposures resulting from changes in these foreign currency exchange rates. These foreign exchange contracts, carried at fair value, have maturities of up to twelve months. The Company enters into these foreign exchange contracts to hedge a portion of its forecasted foreign currency denominated revenue in the normal course of business, and, accordingly, they are not speculative in nature.

15

 STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

Note 11. Equity

a. Stock-based compensation plans

Stock-based compensation expenses for equity-classified stock options, restricted share units (“RSUs”) and performance-based restricted share units (”PSUs”) were allocated as follows:

	Three Months Ended March 31,
		2023		2022
	U.S $ in thousands
Cost of revenues	$	932	$	900
Research and development, net		2,089		1,786
Selling, general and administrative		5,220		5,847
Total stock-based compensation expenses	$	8,241	$	8,533

A summary of the Company’s stock option activity for the three months ended March 31, 2023 is as follows:

		Number of Options			Weighted Average Exercise Price
Options outstanding as of January 1, 2023	$	1,619,559		$	27.62
Granted		-			-
Exercised		(1,083	)		3.58
Forfeited		(2,910	)		34.73
Options outstanding as of March 31, 2023		1,615,566			27.62
Options exercisable as of March 31, 2023	$	1,243,725		$	31.13

As of March 31, 2023, the unrecognized compensation cost of $1.1 million related to all unvested, equity-classified stock options is expected to be recognized as an expense over a weighted-average period of 1.66 years.

16

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

A summary of the Company’s RSUs and PSUs activity for the three months ended March 31, 2023 is as follows:

		Number of RSUs and PSUs			Weighted Average Grant Date Fair Value
Unvested as of January 1, 2023	$	3,496,099		$	23.98
Granted		1,642,257			13.02
Vested		(996,094	)		25.58
Forfeited		(104,741	)		25.03
Unvested as of March 31, 2023	$	4,037,521		$	19.10

The fair value of RSUs and PSUs is determined based on the quoted price of the Company’s ordinary shares on the date of the grant.

As of March 31, 2023, the unrecognized compensation cost of $63.5 million related to all unvested, equity-classified RSUs and PSUs is expected to be recognized as expense over a weighted-average period of 2.4 years.

b. Accumulated other comprehensive loss

The following tables present the changes in the components of accumulated other comprehensive income (loss), net of taxes, for the three months ended March 31, 2023 and 2022, respectively:

	Three Months Ended March 31, 2023
		Net Unrealized Gain (Loss) on Cash Flow Hedges			Foreign Currency Translation Adjustments			Total
	U.S. $ in thousands
Balance as of January 1, 2023	$	(299	)	$	(12,519	)	$	(12,818	)
Other comprehensive income (loss) before reclassifications		(1,828	)		1,255			(573	)
Amounts reclassified from accumulated other comprehensive loss		(417	)		-			(417	)
Other comprehensive income (loss)		(2,245	)		1,255			(990	)
Balance as of March 31, 2023	$	(2,544	)	$	(11,264	)	$	(13,808	)

17

STRATASYS LTD.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)

	Three Months Ended March 31, 2022
		Net Unrealized Gain (Loss) on Cash Flow Hedges			Foreign Currency Translation Adjustments			Total
	U.S. $ in thousands
Balance as of January 1, 2022	$	1,572		$	(10,343	)	$	(8,771	)
Other comprehensive income (loss) before reclassifications		271			(702	)		(431	)
Amounts reclassified from accumulated other comprehensive loss		(622	)		-			(622	)
Other comprehensive income (loss)		(351	)		(702	)		(1,053	)
Balance as of March 31, 2022	$	1,221		$	(11,045	)	$	(9,824	)

Note 12. Contingencies

      The Company is a party to various legal proceedings from time to time, the outcome of which, in the opinion of management, will not have a significant effect on the financial position, profitability or cash flows of the Company.

       

18

65721 67583 0.32 0.33 false --12-31 Q1 2023 2023-03-31 0001517396 001-35751 0001517396 2023-01-01 2023-03-31 0001517396 2023-03-31 0001517396 2022-12-31 0001517396 us-gaap:ProductMember 2023-01-01 2023-03-31 0001517396 us-gaap:ProductMember 2022-01-01 2022-03-31 0001517396 us-gaap:ServiceMember 2023-01-01 2023-03-31 0001517396 us-gaap:ServiceMember 2022-01-01 2022-03-31 0001517396 2022-01-01 2022-03-31 0001517396 us-gaap:CommonStockMember 2022-12-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001517396 us-gaap:RetainedEarningsMember 2022-12-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001517396 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001517396 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001517396 us-gaap:CommonStockMember 2023-03-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001517396 us-gaap:RetainedEarningsMember 2023-03-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001517396 us-gaap:CommonStockMember 2021-12-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001517396 us-gaap:RetainedEarningsMember 2021-12-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001517396 2021-12-31 0001517396 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001517396 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001517396 us-gaap:CommonStockMember 2022-03-31 0001517396 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001517396 us-gaap:RetainedEarningsMember 2022-03-31 0001517396 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001517396 2022-03-31 0001517396 ssys:BusinessCombinationMember 2023-01-01 2023-03-31 0001517396 ssys:MakerBotMember 2022-08-01 2022-08-31 0001517396 2021-02-10 2021-02-16 0001517396 ssys:XAARMember 2021-11-01 0001517396 2021-11-01 2021-11-01 0001517396 ssys:XAARMember 2023-03-31 0001517396 ssys:XAARMember 2023-01-01 2023-03-31 0001517396 2022-01-01 2022-12-31 0001517396 ssys:SystemsMember srt:AmericasMember 2023-01-01 2023-03-31 0001517396 ssys:SystemsMember srt:AmericasMember 2022-01-01 2022-03-31 0001517396 ssys:ConsumablesMember srt:AmericasMember 2023-01-01 2023-03-31 0001517396 ssys:ConsumablesMember srt:AmericasMember 2022-01-01 2022-03-31 0001517396 us-gaap:ServiceMember srt:AmericasMember 2023-01-01 2023-03-31 0001517396 us-gaap:ServiceMember srt:AmericasMember 2022-01-01 2022-03-31 0001517396 srt:AmericasMember 2023-01-01 2023-03-31 0001517396 srt:AmericasMember 2022-01-01 2022-03-31 0001517396 ssys:SystemsMember us-gaap:EMEAMember 2023-01-01 2023-03-31 0001517396 ssys:SystemsMember us-gaap:EMEAMember 2022-01-01 2022-03-31 0001517396 ssys:ConsumablesMember us-gaap:EMEAMember 2023-01-01 2023-03-31 0001517396 ssys:ConsumablesMember us-gaap:EMEAMember 2022-01-01 2022-03-31 0001517396 us-gaap:ServiceMember us-gaap:EMEAMember 2023-01-01 2023-03-31 0001517396 us-gaap:ServiceMember us-gaap:EMEAMember 2022-01-01 2022-03-31 0001517396 us-gaap:EMEAMember 2023-01-01 2023-03-31 0001517396 us-gaap:EMEAMember 2022-01-01 2022-03-31 0001517396 ssys:SystemsMember srt:AsiaPacificMember 2023-01-01 2023-03-31 0001517396 ssys:SystemsMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0001517396 ssys:ConsumablesMember srt:AsiaPacificMember 2023-01-01 2023-03-31 0001517396 ssys:ConsumablesMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0001517396 us-gaap:ServiceMember srt:AsiaPacificMember 2023-01-01 2023-03-31 0001517396 us-gaap:ServiceMember srt:AsiaPacificMember 2022-01-01 2022-03-31 0001517396 srt:AsiaPacificMember 2023-01-01 2023-03-31 0001517396 srt:AsiaPacificMember 2022-01-01 2022-03-31 0001517396 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-03-31 0001517396 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001517396 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-03-31 0001517396 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001517396 us-gaap:TransferredAtPointInTimeMember 2023-01-01 2023-03-31 0001517396 us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001517396 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2023-01-01 2023-03-31 0001517396 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0001517396 us-gaap:TransferredOverTimeMember 2023-01-01 2023-03-31 0001517396 us-gaap:TransferredOverTimeMember 2022-01-01 2022-03-31 0001517396 us-gaap:GoodwillMember 2022-12-31 0001517396 us-gaap:GoodwillMember 2023-01-01 2023-03-31 0001517396 us-gaap:GoodwillMember 2023-03-31 0001517396 us-gaap:DevelopedTechnologyRightsMember 2023-03-31 0001517396 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001517396 us-gaap:PatentsMember 2023-03-31 0001517396 us-gaap:PatentsMember 2022-12-31 0001517396 us-gaap:TrademarksAndTradeNamesMember 2023-03-31 0001517396 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001517396 us-gaap:CustomerRelationshipsMember 2023-03-31 0001517396 us-gaap:CustomerRelationshipsMember 2022-12-31 0001517396 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-03-31 0001517396 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001517396 us-gaap:AssetsMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001517396 us-gaap:AssetsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001517396 us-gaap:AssetsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001517396 us-gaap:AssetsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001517396 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001517396 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001517396 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001517396 us-gaap:AccruedLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001517396 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001517396 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:MeasurementInputConversionPriceMember 2022-03-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember ssys:MeasurementInputConversionOfPriceMember 2022-03-31 0001517396 us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2023-03-31 0001517396 us-gaap:NondesignatedMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2023-03-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001517396 us-gaap:NondesignatedMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember 2023-03-31 0001517396 us-gaap:NondesignatedMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember 2023-03-31 0001517396 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001517396 us-gaap:EmployeeStockOptionMember 2023-03-31 0001517396 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001517396 ssys:RestrictedAndPhantomShareUnitsMember 2023-03-31 0001517396 ssys:RestrictedAndPhantomShareUnitsMember 2023-01-01 2023-03-31 0001517396 us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001517396 us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001517396 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-03-31 0001517396 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-03-31 0001517396 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0001517396 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0001517396 ssys:StockbasedCompensationPlansMember 2023-01-01 2023-03-31 0001517396 ssys:StockbasedCompensationPlansMember 2022-01-01 2022-03-31 0001517396 ssys:RestrictedAndPhantomShareUnitsMember 2022-12-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-03-31 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0001517396 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-03-31 0001517396 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 iso4217:USD iso4217:ILS xbrli:shares xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:ILS iso4217:EUR